Get started
Author

Bhagyabhumi Shah

ORCID: 0000-0002-9477-831X
Observed ORCID: 0000-0002-9477-831X
OpenAlex ID: A5114090543
Ameliorative effect of nodakenin in combating TNBS-induced ulcerative colitis by suppressing NFƙB-mediated NLRP3 inflammasome pathway
2024 · Bhagyabhumi Shah, Nilay Solanki · Naunyn-Schmiedeberg s Archives of Pharmacology · 13
Aegeline attenuates TNBS-induced colitis by suppressing the NFƙB-mediated NLRP3 inflammasome pathway in mice
2024 · Bhagyabhumi Shah, Nilay Solanki · Inflammopharmacology · 13
Exploring the bioactive properties and mechanism of Aegle marmelos in the treatment of inflammatory bowel disease through network pharmacology and a molecular docking approach
2025 · Bhagyabhumi Shah, Nilay Solanki · American Journal of Translational Research · 11
PDF
Integrating network pharmacology and in vivo study to explore the anti-Alzheimer’s potential of Bergenia ligulata and Nelumbo nucifera
2025 · Yamini Patel, Nilay Solanki, et al. · 3 Biotech · 3
Peiminine attenuates inflammatory bowel disease by suppressing TLR4 mediated NFƙB pathway: an integrated network pharmacology and experimental validation
2026 · Bhagyabhumi Shah, Aditi Sharma, et al. · Scientific Reports
Role of Omics in Natural Product-Based Drug Discovery
2026 · Bhagyabhumi Shah, Ruchi Yadav, et al. · Apple Academic Press eBooks
Small Interfering Ribonucleic Acid (siRNA)-Based Therapeutics in Inflammatory Bowel Disease: Crosstalk between Immune Modulation and Epithelial Barrier Restoration
2026 · Mansi Patel, Bhagyabhumi Shah · ACS Pharmacology & Translational Science
Mechanistic Role of Coumarins Useful in Mitigating Inflammatory Bowel Disease
2025 · Bhagyabhumi Shah, Aditi Sharma, et al. · Revista Brasileira de Farmacognosia
Works count: 8
Citation count: 40
H-index: 3
I10-index: 3
Year
Topic
Type